APAF1 and ovarian carcinoma: APAF1 partially abrogated paclitaxel resistance (Fig. 6b), suggesting that besides downregulation of AFAP1, other mechanisms are involved in mediating the effect of miR21 on paclitaxel resistance in ovarian cancer cells.